← FDA DRUG APPROVALS

FDA ANDA · ANDA090903

METRONIDAZOLE

Sponsor: CHARTWELL RX

APPLICATION
ANDA090903
TYPE
ANDA
ORIGINAL APPROVAL
2011-07-22
LATEST ACTION
2023-04-25
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Discontinued

Products

METRONIDAZOLEDiscontinued
METRONIDAZOLE 1% · GEL · TOPICAL

Approval history

2023-04-25Labeling · Supplement 8 · standardAP
2015-12-09Manufacturing (CMC) · Supplement 2 · unknownAP
2011-07-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →